Asymmetrical dendritic compound of the Formula (I) as described herein can contain multiple functional moieties as represented by R
1
and R
2
in Formula (I). In various embodiments, the functional moieties include N-Boc, a targeting ligand, a drug, and/or an imaging agent. A number of such functionalized asymmetrical dendritic compounds can be used for various therapies, including cancer treatment.
根据本文所述的式(I),不对称树突化合物可以包含由式(I)中的R1和R2表示的多个功能基团。在各种实施方式中,功能基团包括N-Boc、靶向
配体、药物和/或成像剂。许多这种功能化的不对称树突化合物可用于各种疗法,包括癌症治疗。